■为了更新和描述疾病特定计划(DSP)的作用,多视角真实世界数据(RWD)源,在临床现实世界证据(RWE)的价值和接受度的演变背景下,监管和指导方针决策。
■DSP是多国家的,多用户,结合患者回顾性数据收集的多治疗横断面调查,护理人员和医生的观点。收集的信息涵盖了患者的旅程,包括治疗/处方模式和基本原理,患者报告的结果,对工作和日常活动的影响,对这种情况的态度和看法,坚持治疗和疾病负担。已发表的经同行评审的DSP论文与文献中确定的当前关键RWE主题保持一致,以及他们对RWE的贡献。
■研究的RWE主题是:使用RWE为临床实践提供信息,患者和护理人员的参与,RWE在支持卫生技术评估和监管提交方面的作用,为价值驱动的医疗保健决策提供信息,真实世界的患者亚组差异和治疗惯性/未满足的需求;突出患者和护理人员与疾病生活的经验,与他们的医生断开连接,未满足的需求和教育差距。
■除了注册管理机构产生的证据外,DSP还提供了丰富的RWD,临床试验和观察研究,广泛用于制药行业,政府,资助/监管机构,临床实践指南见解和,最重要的是,告知人们生活的改善。深度,自1995年以来,通过DSP收集的信息的广度和传统是无与伦比的,扩展对医生在常规临床实践中如何管理疾病以及为什么选择治疗方法的理解,患者对疾病管理的看法,和照顾者的负担。
To update on and describe the role of Disease Specific Programmes (DSPs), a multi-perspective real-world data (RWD) source, in the context of the evolution of the value and acceptance of real-world evidence (RWE) in clinical, regulatory and
guideline decision-making.
DSPs are multi-national, multi-subscriber, multi-therapy cross-sectional surveys incorporating retrospective data collection from patient, caregiver and physician perspectives. Information collected covers the patient journey, including treatment/prescribing patterns and rationale, patient-reported outcomes, impact on work and everyday activities, attitudes towards and perceptions of the condition, adherence to treatment and burden of illness. Published peer-reviewed DSP papers were aligned with current key RWE themes identified in the literature, alongside their contribution to RWE.
RWE themes examined were: using RWE to inform clinical practice, patient and caregiver engagement, RWE role in supporting health technology assessments and regulatory submissions, informing value-driven healthcare decisions, real-world patient subgroup differences and therapeutic inertia/unmet needs; highlighting patients\' and
caregivers\' experience of living with a disease, disconnect from their physicians, unmet needs and educational gaps.
DSPs provide a wealth of RWD in addition to evidence generated by registries, clinical trials and observational research, with wide use for the pharmaceutical industry, government, funding/regulatory bodies, clinical practice
guideline insights and, most importantly, informing improvements in people\'s lives. The depth, breadth and heritage of information collected via DSPs since 1995 is unparalleled, extending understanding of how diseases are managed by physicians in routine clinical practice and why treatment choices are made, patients\' perceptions of their disease management, and caregiver burden.